Correlation Between Molecular Templates and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Entrada Therapeutics, you can compare the effects of market volatilities on Molecular Templates and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Entrada Therapeutics.
Diversification Opportunities for Molecular Templates and Entrada Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Molecular and Entrada is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Entrada Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to generate 2.88 times less return on investment than Entrada Therapeutics. In addition to that, Molecular Templates is 8.41 times more volatile than Entrada Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.21 per unit of volatility. If you would invest 1,737 in Entrada Therapeutics on August 29, 2024 and sell it today you would earn a total of 200.00 from holding Entrada Therapeutics or generate 11.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Entrada Therapeutics
Performance |
| Timeline |
| Molecular Templates |
| Entrada Therapeutics |
Molecular Templates and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Entrada Therapeutics
The main advantage of trading using opposite Molecular Templates and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Molecular Templates vs. Eliem Therapeutics | Molecular Templates vs. Scpharmaceuticals | Molecular Templates vs. Milestone Pharmaceuticals | Molecular Templates vs. Seres Therapeutics |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |